Adenosylcobalamin: The Mitochondrial B12 Form Most Supplements Omit

Most B12 supplements list either cyanocobalamin (the cheap pharmaceutical form) or methylcobalamin (the wellness-market favorite). A third major coenzyme form — adenosylcobalamin, also called 5'-deoxyadenosylcobalamin, dibencozide, or cobamamide — appears far less often despite serving a physiological role the other two cannot replicate. Whether that omission matters depends on what the supplement is trying to do.

Two enzymes, two coenzyme forms

Human cells use vitamin B12 in exactly two enzymatic reactions. Methylcobalamin is the coenzyme for methionine synthase in the cytoplasm, which transfers a methyl group from 5-methyltetrahydrofolate to homocysteine to form methionine. Adenosylcobalamin is the coenzyme for methylmalonyl-CoA mutase inside mitochondria, which converts methylmalonyl-CoA to succinyl-CoA — a critical step in the catabolism of odd-chain fatty acids, branched-chain amino acids (valine, isoleucine), and propionate. The accumulation of methylmalonic acid (MMA) is the classic biochemical signature of B12 deficiency, and reflects insufficient adenosylcobalamin activity specifically [1].

Why the form on the label may not matter much

Ingested cobalamin in any form is largely deconjugated, transported across the enterocyte by intrinsic factor and transcobalamin, and intracellularly converted to the two active forms by the enzymes MMACHC, MMADHC, MMAA, and MMAB. Cells make whichever coenzyme they need. This is why intramuscular cyanocobalamin (whose cyanide moiety is benign at supplementation doses) can correct deficiency just as well as methylcobalamin in most cases [2]. The marketing premise that methylcobalamin is "the active form your body can use directly" is partially true but misleading — methylcobalamin still requires intracellular processing for use in mitochondria, and the body interconverts between forms.

When adenosylcobalamin specifically may matter

The handful of conditions where the form distinction is genuinely relevant involves inborn errors of cobalamin metabolism: cblA, cblB, and cblD-MMA defects impair mitochondrial conversion to adenosylcobalamin and present as methylmalonic aciduria. Some of these respond to high-dose hydroxocobalamin or adenosylcobalamin therapy [3]. In acquired deficiency in older adults, supplementing with adenosylcobalamin (or any form) corrects elevated MMA, but no head-to-head trial demonstrates clinical superiority of adenosylcobalamin over cyanocobalamin or methylcobalamin in routine deficiency replacement.

The combined-form rationale

Some lozenge products combine methylcobalamin, adenosylcobalamin, and hydroxocobalamin. The rationale — providing all coenzyme pools simultaneously — is plausible but not supported by superior outcomes data. The most rigorously studied delivery in research settings is parenteral hydroxocobalamin, which has the longest half-life and is the standard treatment for B12 deficiency in much of Europe [4]. Oral therapy at 1,000-2,000 mcg/day is effective even in patients without intrinsic factor, due to a non-saturable passive absorption pathway that delivers ~1 percent of any oral dose regardless of intrinsic factor status [5].

Cost, stability, and absorption

Adenosylcobalamin and methylcobalamin are both light- and air-sensitive; cyanocobalamin is the most stable in capsule and tablet form. Sublingual delivery is no more bioavailable than oral swallowed cobalamin in the studies that have actually compared them [6]. Cyanocobalamin remains the form used in nearly all national fortification programs because of cost and stability.

The practical conclusion

For routine B12 deficiency correction in adults without inborn errors, the form on the label is a minor consideration. Dose adequacy (1,000 mcg oral daily, or 1,000 mcg intramuscular monthly for malabsorption) and adherence matter more. For people who tolerate oral therapy poorly or who have suspected MMA-cycle issues, adenosylcobalamin is a reasonable choice but not demonstrably superior. The methylcobalamin marketing premium rarely buys meaningful biology over much cheaper alternatives.